We describe an as yet unreported neocentric small supernumerary marker chromosome (sSMC) derived from chromosome 1p21.3p21.2. It was present in 80% of the lymphocytes in a male patient with intellectual disability, severe speech deficit, mild dysmorphic features, and hyperactivity with elements of autism spectrum disorder (ASD). Several important neurodevelopmental genes are affected by the 3.56 Mb copy number gain of 1p21.3p21.2, which may be considered reciprocal in gene content to the recently recognized 1p21.3 microdeletion syndrome. Both 1p21.3 deletions and the presented duplication display overlapping symptoms, fitting the same disorder category. Contribution of coding and non-coding genes to the phenotype is discussed in the light of cellular and intercellular homeostasis disequilibrium. In line with this the presented 1p21.3p21.2 copy number gain correlated to 1p21.3 microdeletion syndrome verifies the hypothesis of a cumulative effect of the number of deregulated genes -homeostasis disequilibrium leading to overlapping phenotypes between microdeletion and microduplication syndromes. Although miR-137 appears to be the major player in the 1p21.3p21.2 region, deregulation of the DPYD (dihydropyrimidine dehydrogenase) gene may potentially affect neighboring genes underlying the overlapping symptoms present in both the copy number loss and copy number gain of 1p21. Namely, the all-in approach revealed that DPYD is a complex gene whose expression is epigenetically regulated by long non-coding RNAs (lncRNAs) within the locus. Furthermore, the long interspersed nuclear element-1 (LINE-1) L1MC1 transposon inserted in DPYD intronic transcript 1 (DPYD-IT1) lncRNA with its parasites, TcMAR-Tigger5b and pair of Alu repeats appears to be the "weakest link" within the DPYD gene liable to break. Identification of the precise mechanism through which DPYD is epigenetically regulated, and underlying reasons why exactly the break (FRA1E) happens, will consequently pave the way toward preventing severe toxicity to the antineoplastic drug 5-fluorouracil (5-FU) and development of the causative therapy for the dihydropyrimidine dehydrogenase deficiency.
introduction
We report a case of a neocentric small supernumerary marker chromosome (sSMC) 
material and methods

Clinical description
The patient was a boy identified by the multiplex ligation-dependent probe amplification (MLPA) screening in individuals with unexplained intellectual disability (ID). He is the fifth child of parents who both function at a borderline intellectual level or mild ID. At the age of 10, the boy and his siblings were placed in foster care homes, as the parents had not been able to take care of them.
According to scant data on his early development, he was born at term after an 
Array-comparative genomic hybridization (arrayCGH)
A genome-targeted copy number profile of the patient's DNA was obtained by subjecting it to microarray analysis using our own custom- 
results
The present case was singled out during MLPA screening in individuals with unexplained ID, which started with subtelomeres screening (P036 and P070) followed by screening for microdeletion syndromes (P245 and P297) and autism (P343-B1), which all showed normal results. Finally, a ME028-PWS/AS probe set was used to exclude possible Angelman syndrome due to uniparental disomy, and the chromosome culture was set up. The methylation pattern was normal. However, the copy number report in repeated experiments revealed a deletion of SNRPN exon1B-b
(copy number variation in this region has been described in healthy individuals too), and duplication of the reference 1p21 probe
05330-L04717 (results not shown). Banding
cytogenetics disclosed a ring shaped sSMC found in 80% of the lymphocytes ( Fig. 2A) . 1 ). In addition, microarray expression data of the transcripts possibly involved in common pathway with the genes comprised in sSMC(1), or commented in the discussion, are shown in [146] are not included in the figure: patients 1-4 originate from highly consanguineous families; for the patient 5 (~14 Mb, del1p21.3p13.3), no coordinates or most proximal-most distal genes are quoted. . Expression patterns of selected transcripts in the human brain. The microarray expression data were analyzed for affected transcripts in 1p21.3p21.2 and those discussed in the paper in 16 brain regions and 13 developmental periods. Samples colored dark blue are considered unexpressed (cutoff value <5.5). Note that the range of expression intensity is displayed with each transcript profile. Spatiotemporal expression profiles of brain regions and neocortical areas (NCX) were obtained from the Yale's genome-wide exon-level transcriptome data base (www.humanbraintranscriptome.org). MiR124-1 microarray expression data shows overall moderate expression level in the brain, except in cerebral cortex during early mid-fetal period (16-19 PCW). However, from neonatal period until adulthood miR124-1 expression level is consistently high in cerebellum. MiR124-2 expression level is high prenatally during major neurodevelopmental processes in all examined cerebral cortical areas, thalamus, basal ganglia and cerebellum until late mid-fetal period when its expression decreases, especially in cerebellum, hippocampus and striatum. PTBP2 shows similar expression pattern like miR124-2, which is consistent with the finding that miR-124 downregulates PTBP1, leading to upregulation of PTBP2. PTBP2 expression level is consistently high in all brain regions until late mid-fetal period, a crucial neurodevelopmental period for major histogenetic events and formation of neocortical circuits. After 24PCW its expression is downregulated. In contrast, DLG4 (PSP-95) shows moderate expression level in cerebrum and cerebellum until neonatal time, when expression is upregulated in all examined regions (consistent with alternative splicing regulation of PSD-95; PSD-95 is post-transcriptionally repressed by PTBP2, which thus temporarily inhibits the expression of "adult" protein isoforms until neurons have matured) and remain high throughout adulthood. The PTBP1 expression level is consistently low in all neocortical areas, except visual. However, its expression is high prenatally in amygdala, cerebellum and hippocampus until neonatal period when is downregulated. The RAVER1 expression pattern is relatively low throughout lifetime and it shows lowest level during childhood. RAVER2 displays spatiotemporal differential expression pattern in different cortical areas; namely: in prefrontal cortex is highest during perinatal time, while in some cortical areas (like visual) is highly expressed from early fetal until early infancy. RAVER2 expression level is lower from late childhood throughout adulthood in all cortical areas. On a contrary, expression level remains more stable in other brain regions, such as thalamus and basal ganglia. MiR-137 expression is highly expressed prenatally in neocortex and amygdala, but its expression is decreased perinatally and remains low postnatally. According to microarray data, it is not expressed in cerebellum throughout life span. MIB1 shows highest expression during early fetal time in all examined regions of the brain and gradually decreases from early mid-fetal onward in all examined regions, except in cerebellum. SNX7 shows highest expression in neocortical areas, amygdale and hippocampus from early fetal to perinatal period, during the time of major neurodevelopmental processes. Its expression level decreases postnatally. Cerebellum and striatum do not show expression throughout whole life span. MiR9-2 expression level is high from early fetal until neonatal period in all examined brain regions except thalamus. LPPR5 expression is high in all examined brain regions throughout whole life span, except in the cerebellum where it remains lower, except during perinatal period. LPPR4 shows highest expression in neocortical areas, especially during late mid-fetal, neonatal, infancy and childhood during intense synaptogenesis and dendritic differentiation. Its expression is lowest in cerebellum and thalamus throughout life span. DPYD shows substantial spatiotemporal variation in expression pattern throughout lifespan. It is not expressed during early fetal time in the brain and it shows the highest expression level in temporal lobe and amygdale during early and late mid-fetal period. Cerebellum and thalamus do not express it throughout all examined periods. Relatively low LOC100129620 expression can be observed in neocortex from early to late mid-fetal period. LOC729987 is not expressed in any analyzed region or time point. EZH2 is not expressed in the brain throughout lifespan, except in several samples prenatally. SNX14 starts to be expressed at early mid-fetal period and remains to be moderately expressed throughout lifespan. 
discussion
Long non-coding RNAs (lncRNAs): LOC10192824, LOC729987 and LOC100129620
The major classes of non-protein coding RNAs changes to other structures in the lncRNA [19] .
Hence, it comes as no surprise that some of them are implicated in psychiatric, neurological and neurodegenerative disorders [21] . One of the best studied examples is an antisense long ncRNA BDNF-AS [22] that acts as a regulator of expression of brain derived neurotrophic Recent studies suggest that expression of miRNAs and their targets are dynamically regulated, both spatially and temporally, contributing to the diversity and plasticity of our brain [35] . It has been shown that many miRNAs also act locally, at the growth cone or at synapses, modulating synaptic plasticity and neuronal connectivity, thereby contributing to the dynamic spatial organization of axonal and dendritic structures and their function [36, 37] .
A neuron-enriched miRNA, miR-137 plays an important role in the regulation of cell proliferation and differentiation [38] [39] [40] [41] .
Micro RNA miR-137 is enriched at the synaptic compartment [36, 37, 39, 42] and regulates neuronal maturation influencing dendritic patterning and spine morphogenesis [43] [44] [45] through silencing of Mind bomb one (Mib1),
an ubiquitin ligase known to be important for neurogenesis [39, [46] [47] [48] . (Fig. 4) .
Through cross-regulatory network, PTBP2
temporarily inhibits the expression of "adult"
protein isoforms until neurons have matured [65, 73, 74] , demonstrating an essential role in controlling the brain's early development.
These proteins all affect neurite outgrowth, axon guidance, synaptic assembly, and synaptic function; their untimely expression would lead to aberrant neuronal network development [73] . The expression of PTBP2 continues after differentiation, and is present in the brain at moderate levels through adulthood [73] (Fig.   4 ), but its role in differentiating neurons is not fully understood.
The loss of PTBP2, as demonstrated in PTBP2
null generated mice (Ptbp2-/-), does not greatly affect developmental patterning of CNS.
However, post-mitotic neuronal maturation and survival are severely impaired, as a result of misexpression of many protein isoforms affecting neurite growth, synapse formation and synaptic transmission [73] . Similarly, when neurons lacking PTPB2 are grown in culture, they fail to develop correctly and die.
Overexpression of PTBP1 and PTBP2 in cultured neurons was shown to repress synaptic activity, spine formation/morphogenesis, and reduce PSD-95 transcript [68, 73] . The study of Li et al. [73] showed that PTBP2 is critical to both embryonic and postnatal brain development. regulates chromatin structure to silence gene expressions [81, 82] . An increasing body of evidence suggests that EZH2 plays a critical role in stem cell maintenance and differentiation into specific cell lineages, including neurogenesis, adipogenesis and osteogenesis [81, 83, 84] .
Recent studies report that craniofacial skeleton formation in higher vertebrates is crucially dependent on epigenetic regulation [85] , and that the switch between adipogenesis and osteogenesis can be epigenetically regulated by phosphorylation of EZH2, which suppresses PCR2 catalytic activity [81, 86, 87] . In addition, recent exome-sequencing studies identified missense mutations and in-frame deletions of EZH2 in patients with Weaver's syndrome, an autosomal dominant disease characterized by learning disabilities, dysmorphic facial features and general overgrowth, which can include tall stature, obesity and macrocephaly [88] .
Mutations of EZH2 are also reported in a cohort of patients with a nonspecific overgrowth syndrome [89] . Interestingly, the patients with 1p21.3 deletions display (borderline) macrocephaly and a tendency to be overweight or Twist-2 deficiency leads to premature osteoblast differentiation [90] .
Micro RNA miR-137 can also influence tooth development. One of the putative targets of miR-137 is AXIN1, which is the key component of canonical Wnt pathway [92] . Vertebrates have two AXIN homologous genes (AXIN1 and AXIN2) [93] which appear to be functionally equivalent and interchangeable in Wnt pathway [94] . Loss of Axin2 function is linked to carcinogenesis as well as abnormal bone and tooth development, including hypodontia [94, 95] . In addition to AXIN1, three other genes are among putative miR-137 targets involved in dental development according to TargetScan: BCOR (BCL6 Corepressor; transcriptional regulator), BCORL1 (BCL6 Corepressor-Like 1) [96, 97] and PVRL1 (NECTIN1), respectively [98] .
Thus, gain or loss of miR-137 function could affect both osteogenesis and dentition.
However, it appears that osteogenesis and dentition are more affected in 1p21.3/miR-137 copy number gain, though the influence of other genes cannot be ruled out. is considered a putative regulator of neuronal plasticity.
Micro
It has been shown that lack of LPPR4 leads to juvenile epileptic seizures in mice 
Sortin nexin 7 (SNX7)
Sorting nexin 7 (SNX7) belongs to a large family of proteins involved in intracellular trafficking.
Its exact function is unknown and apart from a single study on zebrafish [110] , no report on SNX7 in rodents/humans is cited in PubMed. (Fig. 4) .
SNX14 localizes to the cytoplasm and dendrites of dissociated mouse cortical neurons where
it regulates neuronal intrinsic excitability and promotes synaptic transmission [122] .
SNX7 is a putative target of a single broadly and the onset of neuronal differentiation [127] .
Recent studies link miR-9 with a number of neurodegenerative disorders [128] . The spatiotemporal expression pattern of SNX7 is similar to that of miR-9-2 throughout the life span; the exception is perinatal downregulation of SNX7 in cerebellum and striatum suggesting the possibility of being silenced by miR-9 (Fig. 4) .
Dihydropyrimidine dehydrogenase (DPYD) gene 4.8.1. DPYD: the clinics
The DPYD (dihydropyrimidine dehydrogenase) 
DPYD: molecular organization
In accordance with the GRCh38/hg38 annotation, the main known components of types of cancers [166] [167] [168] .
NATs are located within many imprinted loci [169] [170] [171] [172] [173] [174] and may be directly involved in modulating gene expression within the imprinted cluster. The classic example is the Angelman syndrome gene, UBE3A, which is subject to genomic imprinting but not by differential DNA methylation at the promoter region [175] . Instead, UBE3A is regulated by its antisense NAT UBE3A-ATS in cis, which is expressed from the paternally inherited chromosome in the brain and is also imprinted [147, 176] .
Although up to 80% of protein coding genes have transcriptionally active introns containing intronic lncRNA genes, little is known about their function [177] [178] [179] . Intronic ncRNAs are predominantly associated with the sense strand of the unprocessed mRNA, which is also the case with the DPYD-IT1. However, intronic lncRNAs often show expression patterns which are opposite to the processed mRNA [156, [180] [181] [182] .
This suggests a complex regulatory relationship in which intronic lncRNA transcription is independent from the transcription of protein coding pre-mRNA [177] [178] [179] . Intronic lncRNAs may be transcribed from either the sense or antisense strand of the protein-coding gene in which they are encoded [183] [184] [185] . Recent work also indicates that many intron-derived RNAs, like many other lncRNAs, function through recruitment of the Polycomb repressive complex 2 (PRC2), leading to subsequent transcriptional repression [186, 187] . Interestingly, DPYD-IT1 is located within the intron 14, which is the major locus responsible for dihydropyrimidine dehydrogenase deficiency. Namely, the most prominent mutation of the DPYD gene that results in severe DPD deficiency is the G to A mutation in the GT 5'-splice recognition site of intron 14 (exon 14-skipping mutation leading to exon 14 deletion). The corresponding mRNA exhibits 165 bp deletion and the enzymatic activity of the translated DPD protein is virtually absent [188] .
Another class of lncRNAs, long intergenic ncRNAs (lincRNAs), carries out its regulatory role in trans, affecting chromatin conformation and gene expression at distant loci. Transcription Figure 6 . Computational and by BAC FISH predicted coordinates of FRA1E fragile CFS site. FISH predicted FRA1E 185 kb core [195] compared with a computational predicted FRA1E [196] . Note the overlaps between 5'-end of DPYD-IT1 and telomeric border of computational FRA1E prediction marked by red arrow, and between 5'-end of intron 14 and pathogenic splice variant rs391890/c.1905+1G>A, respectively. Coordinates are in GRCh37/hg19 annotation (The NCBI38 has no more capacity to outline the Ensembl annotated genes). P1 stands for BAC FISH predicted core of FRA1E; P2 stands for computational prediction of FRA1E. 
DPYD: common fragile FRA1E site
By partially overlapping bacterial artificial chromosome (BAC) and P1-derived artificial chromosome (PAC) clones, Hormozian et al. [195] determined that the FRA1E common fragile site extends over 370 kb of genomic region of 1p21 laying within DPYD (from intron 8-18). They estimated that the 185 kb region (BAC clone RP11-359C24) of the highest fragility, which accounts for 86% of all observed breaks at FRA1E, encompasses the central part of DPYD, including exons 13-16.
In a genome-wide analysis of common fragile sites (CFS), Fungtammasan et al. [196] computationally predicted the coordinates of 18 CFS including FRA1E, which was found to span over 500 kb of the 1p21.3 genomic region. The computationally defined FRA1E site was among four out of 18 analyzed CFSs whose coordinates did not overlap with cytogenetically defined coordinates [197, 198] . Discordant results may be explained by both cytogenetic banding and fluorescent mapping methods (on which the multiple standard regression model was derived and estimated), which have inherent technical limitations that contribute to variation among coordinates [196] .
In order to correlate both FRA1E range (Fig. 6 ).
The computer search involving almost the whole 843 kb DPYD sequence, both NATs, intron 14 and DPYD-IT1 (retrieved from NCBI GeneBank and/or Ensembl Browser), for specific DNA repeats and secondary structures that can inhibit replication fork progression [197, [199] [200] [201] [202] , led us to a conclusion that no definite deduction may be drawn, particularly while current evidence suggests that CFSs are caused by an interplay of multiple genomic factors [203] [204] [205] .
Nevertheless, questions may be raised whether the FRA1E fragile site is a CFS, or where the cluster(s) of loci liable to break precisely The immediate focus was on a splice-site, exon skipping mutation at 5'-end of intron 14. Subsequently, other variants also proven to be pathological should be taken into consideration. In such cases only 3-5% [206] of the overall population with true DPD deficiency and additional 2%-3% [140] of the population with partial DPD deficiency due to sequence variation would display the "FRA1E" fragile site;
these assumptions may be easily verified in case controlled studies. In favor of such assumption speaks the fact that FRA1E belongs to the group of CFSs with lower expression than FRA3B or FRA16D [197] , and that many sequence motifs spread throughout the aCFS region may contribute to fragility [204, 207, 208] .
Given that the core of the fragile FRA1E site (Fig. 6 ).
We believe that the site most liable to display a breakage, sort of the "weakest link", maps within L1MC1 transposable autonomous long interspersed nuclear element-1 (LINE-1, L1) element, inserted in DPYD intronic transcript 1 (DPYD-IT1) intronic lncRNA gene (Fig. 7A-B ). More precisely, the manner in which the Tigger5b DNA element within L1MC1 is incorporated in the host DNA might be the true "weakest link" within the DPYD gene.
LINE-1 transposons
Transposable elements (TEs) are mobile repetitive sequences that make up at least 45% of the human genome [209] . al. [212] , Kines et al. [220] , Kines and Belancio [221] , Belancio et al. [222] , Belancio et al. [223] , and Wallace et al. [224] ; for comprehensive information see the original papers.
The most active autonomous non-LTR element is long interspersed nuclear element-1, LINE-1 (L1), which contains a number of highly successful parasitic elements [225, 226] . Transcription of a L1 generates a retrotranspositionally competent, full-length L1 mRNA [214, 227] and a spectrum of processed L1-related RNA products, the majority of which are not capable of retrotransposition [228, 229] .
The full-length L1 mRNA is bicistronic and is influenced by the upstream genomic sequence expression [230] . The functional structure of One of the hypotheses is that its role is to interfere with the transcription initiated within upstream sequences to secure transcription from the sense L1 promoter. Alternatively, the L1 antisense promoter is implicated in the production of small interfering RNAs (siRNAs) that inhibit L1 expression [235, 236] . Both of these promoters can modify the normal gene expression. Independent of the orientation of the L1 insert (forward or reverse relative to gene expression) they have the potential for "gene breaking" by generating 5'-truncated genomic transcripts [237] .
The L1 promoter activity is regulated by epigenetic modifications [238, 239] . 
DNA transposons
The human genome contains about seven major probably not be repaired correctly [212] .
TEs are also a widely used tool for insertional mutagenesis. Namely, the TE can disrupt the gene's function in a reversible manner, and after the transposase-mediated excision of the DNA transposon, the gene function may be restored. 
DPYD-IT1: L1MC1, Tigger5b and Alu elements
L1MC1 appears to be a fairly long (9.4 kb) full length L1 LINE element, nested into the genomic DNA, and could therefore be among about a hundred L1 transposons still not dormant in the human genome. The status of L1MC1 activity may depend on the epigenetic (de)regulation of the DPYD, but it could also be the part of epigenetic machinery controlling the DPYD function since it resides within an intronic lncRNA gene.
Though probably inactivated epigenetically or
by acquired mutation, the environmental stress could potentially awake L1MC1 element, since some TEs contain heat-shock like promoters and their rate of transposition increases if the cell is subjected to stress [285] .
Moreover, the whole structure of L1MC1 with nested Tigger5b fragments and pair of Alu repeats (Fig. 7A-B 
conclusion
Even a superficial attempt to comment on the functioning of coding and non-coding sequences comprised in sSMC (1) 
